Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
Plus components not separately reported this period.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
FAQ
- What is Ocular Therapeutix's EBIT?
- Ocular Therapeutix (OCUL) reported EBIT of -$93.34M in Q1 2026.
- How has Ocular Therapeutix's EBIT changed year-over-year?
- Ocular Therapeutix's EBIT decreased by 46.0% year-over-year, from -$63.92M to -$93.34M.
- What is the long-term trend for Ocular Therapeutix's EBIT?
- Over 4 years (2021 to 2025), Ocular Therapeutix's EBIT has grown at a 36.4% compound annual growth rate (CAGR), from -$78.04M to -$270.02M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Ocular Therapeutix's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude